|4Jun 4, 9:01 PM ET

HALKUFF DAWN 4

4 · XERIS PHARMACEUTICALS INC · Filed Jun 4, 2020

Insider Transaction Report

Form 4
Period: 2020-06-04
HALKUFF DAWN
Director
Transactions
  • Award

    Stock Option (right to buy)

    2020-06-04+11,22811,228 total
    Exercise: $4.68Exp: 2030-06-04Common Stock (11,228 underlying)
Footnotes (1)
  • [F1]Such options will vest in full upon the earlier to occur of June 4, 2021 or the date of the Company's next annual meeting of stockholders.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION